BullFrog AI vs Lexaria Bioscience
BFRG and LEXX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BFRG and LEXX compare
Lexaria Bioscience is the larger company, worth 12 times as much as BullFrog AI ($109M against $9.0M).
Lexaria Bioscience scores higher on the StockData Score (8 against 3 for BullFrog AI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BFRG | LEXX |
|---|---|---|
| Size and price | ||
| Market cap | $9.0M | $109M |
| Share price | $0.488 | $4.41 |
| Change, 1 year | −51.2% | −73.3% |
| Change, 5 years | – | −94.5% |
| Beta (5Y) | 4.87 | 0.06 |
| Employees | 9 | 134 |
| StockData Score | ||
| Total score | 3 | 8 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 563× |
| P/B | 1.3× (better) | 23.1× |
| FCF yield | – | −6.8% |
| Growth | ||
| Revenue growth (TTM) | – | −68.5% |
| Revenue growth, 5Y average | – | 17.5% |
| Profitability | ||
| Gross margin | – | 100% |
| Operating margin | – | −3973% |
| Net margin | – | −3986% |
| FCF margin | – | −3849% |
| Return on equity | −131% (better) | −150% |
| Return on invested capital | – | −602% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −1105.4× | – |
| Current ratio | 10.57 | 10.60 (better) |
| Altman Z-score | 1.34 | 125.64 (better) |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Buyback yield | −111% | −6.0% (better) |
| Shareholder yield | −111% | −6.0% (better) |
| Ownership | ||
| Held by institutions | 7.5% | – |
| Held by insiders | 13.7% | 3.0% |
| Insider net buying, 12 months | $71.5K | – |
| Short interest, % of float | – | 0.90% |
Go deeper
- BFRG stock overview
- BFRG income statement
- BFRG valuation and score
- LEXX stock overview
- LEXX income statement
- LEXX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.